[-2]proPSA improves prostate cancer detection: An EDRN validation study

被引：0
|
作者：
Sokoll, Lori J. [1 ]
Wang, Yinghui [2 ]
Feng, Ziding [2 ]
Kagan, Jacob [3 ]
Partin, Alan W. [1 ]
Sanda, Martin G. [4 ]
Thompson, Ian M. [5 ]
Chan, Daniel W. [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[3] Natl Canc Inst, Bethesda, MD USA
[4] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[5] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
来源：
CANCER BIOMARKERS | 2008年 / 4卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：135 / 135
页数：1
相关论文
共 50 条
  • [41] ACCESS [-2]PROPSA AND BECKMAN COULTER PROSTATE HEALTH INDEX (PHI) AND EARLY DETECTION OF AGGRESSIVE PROSTATE CANCERS
    Bektic, J.
    Darte, C.
    Skradski, V.
    Steiner, E.
    Schaefer, G.
    Bartsch, G.
    Horninger, W.
    Klocker, H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 309 - 309
  • [42] Validation of Prostate Imaging Reporting and Data System Version 2 for the Detection of Prostate Cancer
    Hofbauer, Sebastian L.
    Maxeiner, Andreas
    Kittner, Beatrice
    Heckmann, Robin
    Reimann, Maximillian
    Wiemer, Laura
    Asbach, Patrick
    Haas, Matthias
    Penzkofer, Tobias
    Stephan, Carsten
    Friedersdorff, Frank
    Fuller, Florian
    Miller, Kurt
    Cash, Hannes
    JOURNAL OF UROLOGY, 2018, 200 (04): : 767 - 772
  • [43] Validation study of urinary metabolites as potential biomarkers for prostate cancer detection
    Gamagedara, Sanjeewa
    Kaczmarek, Anthony T.
    Jiang, Yongqing
    Cheng, Xiaoling
    Rupasinghe, Maduka
    Ma, Yinfa
    BIOANALYSIS, 2012, 4 (10) : 1175 - 1183
  • [44] Utility of PSA isoform-[-2]proPSA (p2PSA) and prostate health index in the diagnosis of prostate cancer: A study in Indian population
    Govinda, Raju N. L.
    Bhat, Parineetha
    Nagini, S.
    JOURNAL OF KRISHNA INSTITUTE OF MEDICAL SCIENCES UNIVERSITY, 2022, 11 (01) : 45 - 54
  • [45] THE ISOFORM [-2]PROPSA AND THE PROSTATE HEALTH INDEX (PHI) IMPROVE THE DETECTION OF PROSTATE CANCER FOR PATIENTS WITH TOTAL PSA BETWEEN 1.8 AND 8.0 NG/ML
    Blanchet, J-S
    Houlgatte, A.
    Durand, X.
    Ramirez, J. N.
    Bensalah, K.
    Guille, B.
    Vincendeau, S.
    TUMOR BIOLOGY, 2010, 31 : S120 - S120
  • [46] THE [2]PROPSA AND THE PROSTATE HEALTH INDEX (PHI) IMPROVE THE DETECTION OF PROSTATE CANCER FOR PATIENTS WITH TOTAL PSA BETWEEN 1 8 AND 80 NG/ML
    Blanchet, J. S.
    Houlgatte, A.
    Durand, X.
    Ramirez, J. N.
    Bensalah, K.
    Guille, B.
    Vincendeau, S.
    JOURNAL OF MENS HEALTH, 2010, 7 (03) : 345 - 345
  • [47] Clinical Use of [-2] proPSA (p2PSA) and Its Derivatives (%p2PSA and Prostate Health Index) for the Detection of Prostate Cancer: A Review of the Literature
    Abrate, Alberto
    Lughezzani, Giovanni
    Gadda, Giulio Maria
    Lista, Giuliana
    Kinzikeeva, Ella
    Fossati, Nicola
    Larcher, Alessandro
    Dell'Oglio, Paolo
    Mistretta, Francesco
    Buffi, Nicolomaria
    Guazzoni, Giorgio
    Lazzeri, Massimo
    KOREAN JOURNAL OF UROLOGY, 2014, 55 (07) : 436 - 445
  • [48] PSA, PSA derivatives, proPSA and prostate health index in the diagnosis of prostate cancer
    Ayyildiz, Sema Nur
    Ayyildiz, Ali
    TURKISH JOURNAL OF UROLOGY, 2014, 40 (02): : 82 - 88
  • [49] Serum marker %[-2]proPSA and the Prostate Health Index improve diagnostic accuracy for clinically relevant prostate cancer
    Veltri, Robert W.
    BJU INTERNATIONAL, 2016, 117 (01) : 12 - 13
  • [50] Clinical performance of serum proprostate-specific antigen isoform[-2] proPSA in prostate cancer
    闫存玲
    ChinaMedicalAbstracts(InternalMedicine), 2016, 33 (01) : 2 - 3
12345